A phase 2 study of single agent ibrutinib for first‐line treatment of chronic graft‐versus‐host disease: A new paradigm and lessons learned
Authors:
- 5 May 2025
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 206 (6) , 1822-1827
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Chronic Graft-versus-host Disease, Part 2: Clinical Success and Roadmap to the FutureTransplantation, 2025
- Axatilimab in Recurrent or Refractory Chronic Graft-versus-Host DiseaseNew England Journal of Medicine, 2024
- Treatment of newly diagnosed moderate or severe chronic graft-versus-host disease with prednisone and everolimus (PredEver first): a prospective multicenter phase IIA studyBone Marrow Transplantation, 2024
- Steroid-free first line treatment of moderate and severe chronic GVHD: a survey from the Transplant Complications Working Party of the EBMTBone Marrow Transplantation, 2022
- National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2020 Treatment of Chronic GVHD ReportTransplantation and Cellular Therapy, 2021
- How we can mitigate the side effects associated with systemic glucocorticoid after allogeneic hematopoietic cell transplantationBone Marrow Transplantation, 2021
- Trial in Progress: A Phase 3 Study of Itacitinib or Placebo in Combination with Corticosteroids As Initial Treatment for Chronic Graft-Versus-Host Disease (GRAVITAS-309)Blood, 2019
- Ibrutinib for chronic graft-versus-host disease after failure of prior therapyBlood, 2017
- Measuring Therapeutic Response in Chronic Graft-versus-Host Disease. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2014 Response Criteria Working Group ReportTransplantation and Cellular Therapy, 2015
- National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. Diagnosis and Staging Working Group ReportTransplantation and Cellular Therapy, 2005